How can the pharma industry capitalize on the growth potential of emerging markets?

There are many hurdles in drug development, but your chances of success increase significantly if you pay more attention to API optimization from the outset.

Grant Lindman is director of Eli Lilly’s global anticounterfeiting operations and is passionate about fighting fake medicines.

Personalized cell-based therapies have been hyped as the future of medicine, but are current manufacturing technologies up to the task?

Recently, Tim Mackey and colleagues examined the extent to which counterfeit drugs had penetrated global legitimate supply chains.

Two antibody samples were characterized using column calibration and multi-detection SEC, and the results compared...

This application note describes how and when can kinetic information be retrieved from ITC power curves.

Single-use technology is ready to lend a helping hand to biomanufacturing, but is the industry ready to turn away from stainless steel?

Regulators are driving serialization and tamper-evident packaging initiatives, but is the pharma industry fully primed to defend against counterfeits?

Lawrence (Larry) Lesko is a bioanalytical veteran with many years of academic and FDA experience under his belt.